Literature DB >> 19096950

Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.

Weihua Liao1, Yunhai Liu, Xiaoyi Wang, Xinya Jiang, Beisha Tang, Jiasheng Fang, Changqing Chen, Zhongliang Hu.   

Abstract

BACKGROUND: Preoperative differentiation of primary central nervous system lymphomas (PCNSLs) from other tumors is important for presurgical staging, intraoperative management, and postoperative treatment. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging (DSC perfusion MRI) can provide in vivo assessment of the microvasculature in intracranial mass lesions.
PURPOSE: To determine the utility of DSC perfusion MRI in the differentiation of PCNSLs and high-grade gliomas, as well as their pathological and physiological differences.
MATERIAL AND METHODS: Nine patients with pathologically proven PCNSLs and 11 patients with high-grade gliomas were examined using a 1.5 T MRI scanner. DSC perfusion MRI was performed by gradient-echo echo-planar imaging (GE-EPI). The maximum rCBV ratio, the signal intensity-time curves, and the percentage of signal intensity recovery were obtained. The maximum relative cerebral blood volume (rCBV) ratio and the percentage of signal intensity recovery of PCNSLs were compared with those of high-grade gliomas by using Student's t test. Microvessel density (MVD) was evaluated using immunohistochemical staining of surgical specimens with anti-CD34, and MVDs of the two tumor groups were compared by using Student's t test.
RESULTS: The maximum rCBV ratio of primary intracranial lymphomas was 1.72+/-0.59, while that of high-grade gliomas was 4.86+/-2.18. PCNSLs tended to have relatively low perfusion compared to high-grade gliomas (P=0.001), and the MVD labeled by anti-CD34 of PCNSLs was much lower than that of gliomas (P<0.001). The signal intensity-time curve of primary intracranial lymphomas was different from that of high-grade gliomas. The percentage of signal intensity recovery was significantly greater in PCNSLs compared with that of high-grade gliomas (P<0.001).
CONCLUSION: The difference in DSC perfusion MRI characteristics between PCNSLs and high-grade gliomas is determined by their different vascularities and different patterns of contrast agent leakage. This difference may be helpful in the diagnosis and preoperative differentiation between PCNSLs and high-grade gliomas, which sometimes may have similar conventional MR imaging appearance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19096950     DOI: 10.1080/02841850802616752

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  40 in total

1.  Multiple calcified primary central nervous system lymphoma with immunodeficiency in a child.

Authors:  Jing-Qi Zhu; Nan-Xin Hao; Wei-Qun Bao; Xiang-Ru Wu
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain.

Authors:  R Mangla; B Kolar; T Zhu; J Zhong; J Almast; S Ekholm
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-21       Impact factor: 3.825

3.  Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  Z Xing; R X You; J Li; Y Liu; D R Cao
Journal:  Clin Neuroradiol       Date:  2013-08-31       Impact factor: 3.649

4.  ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain.

Authors:  K Welker; J Boxerman; A Kalnin; T Kaufmann; M Shiroishi; M Wintermark
Journal:  AJNR Am J Neuroradiol       Date:  2015-04-23       Impact factor: 3.825

5.  Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.

Authors:  Hie Bum Suh; Yoon Seong Choi; Sohi Bae; Sung Soo Ahn; Jong Hee Chang; Seok-Gu Kang; Eui Hyun Kim; Se Hoon Kim; Seung-Koo Lee
Journal:  Eur Radiol       Date:  2018-04-06       Impact factor: 5.315

6.  Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.

Authors:  Ji Ye Lee; Atle Bjørnerud; Ji Eun Park; Bo Eun Lee; Joo Hyun Kim; Ho Sung Kim
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

Review 7.  Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours.

Authors:  Ananya Chakravorty; Timothy Steel; Joga Chaganti
Journal:  Neuroradiol J       Date:  2015-10-16

8.  Gliosarcoma: a clinical and radiological analysis of 48 cases.

Authors:  Xiaoping Yi; Hang Cao; Haiyun Tang; Guanghui Gong; Zhongliang Hu; Weihua Liao; Lunquan Sun; Bihong T Chen; Xuejun Li
Journal:  Eur Radiol       Date:  2018-06-12       Impact factor: 5.315

9.  Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.

Authors:  M D Lee; G L Baird; L C Bell; C C Quarles; J L Boxerman
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

10.  Ex-vivo HRMAS of adult brain tumours: metabolite quantification and assignment of tumour biomarkers.

Authors:  Alan J Wright; Greg A Fellows; John R Griffiths; M Wilson; B Anthony Bell; Franklyn A Howe
Journal:  Mol Cancer       Date:  2010-03-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.